Cargando…

Plasma Levels and Diagnostic Utility of VEGF in a Three-Year Follow-Up of Patients with Breast Cancer

Breast cancer is the most common malignancy in women globally. The increasing worldwide incidence of this type of cancer illustrates the challenge it represents for healthcare providers. Therefore, new tumor markers are constantly being sought. The aim of this study was to assess plasma concentratio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Będkowska, Grażyna E., Gacuta, Ewa, Zbucka-Krętowska, Monika, Ławicki, Paweł, Szmitkowski, Maciej, Lemancewicz, Adam, Motyka, Joanna, Kobus, Agnieszka, Chorąży, Monika, Paniczko, Marlena, Ławicki, Sławomir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624052/ https://www.ncbi.nlm.nih.gov/pubmed/34830735 http://dx.doi.org/10.3390/jcm10225452

Ejemplares similares

Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC Analysis
por: Zajkowska, Monika, et al.
Publicado: (2018)

The plasma concentration of VEGF, HE4 and CA125 as a new biomarkers panel in different stages and sub-types of epithelial ovarian tumors
por: Ławicki, Sławomir, et al.
Publicado: (2013)

Plasma levels of M-CSF and VEGF in laboratory diagnostics and differentiation of selected histological types of cervical cancers
por: Sidorkiewicz, Iwona, et al.
Publicado: (2019)

Plasma Levels of Metalloproteinase 3 (MMP-3) and Metalloproteinase 7 (MMP-7) as New Candidates for Tumor Biomarkers in Diagnostic of Breast Cancer Patients
por: Ławicki, Paweł, et al.
Publicado: (2023)

Plasma levels and diagnostic utility of VEGF, MMP-9, and TIMP-1 in the diagnosis of patients with breast cancer
por: Ławicki, Sławomir, et al.
Publicado: (2016)

M-CSF in a new biomarker panel with HE4 and CA 125 in the diagnostics of epithelial ovarian cancer patients
por: Będkowska, Grażyna Ewa, et al.
Publicado: (2015)

Diagnostic Power of Cytokine M-CSF, Metalloproteinase 2 (MMP-2) and Tissue Inhibitor-2 (TIMP-2) in Cervical Cancer Patients Based on ROC Analysis
por: Lubowicka, Emilia, et al.
Publicado: (2019)

Diagnostic Power of Vascular Endothelial Growth Factor and Macrophage Colony-Stimulating Factor in Breast Cancer Patients Based on ROC Analysis
por: Zajkowska, Monika, et al.
Publicado: (2016)

Plasma Levels and Diagnostic Utility of Macrophage Colony-Stimulating Factor, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinases-1 as New Biomarkers of Breast Cancer
por: Ławicki, Sławomir, et al.
Publicado: (2016)

Plasma Levels of CXC Motif Chemokine 1 (CXCL1) and Chemokine 8 (CXCL8) as Diagnostic Biomarkers in Luminal A and B Breast Cancer
por: Motyka, Joanna, et al.
Publicado: (2022)

Plasma levels of MMP-7 and TIMP-1 in laboratory diagnostics and differentiation of selected histological types of epithelial ovarian cancers
por: Będkowska, Grażyna Ewa, et al.
Publicado: (2017)

CXCL12 and CXCR4 as Potential Early Biomarkers for Luminal A and Luminal B Subtypes of Breast Cancer
por: Motyka, Joanna, et al.
Publicado: (2023)

Therapy of psoriasis with narrowband ultraviolet-B light influences plasma concentrations of MMP-2 and TIMP-2 in patients
por: Głażewska, Edyta Katarzyna, et al.
Publicado: (2016)

Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer
por: Zajkowska, Monika, et al.
Publicado: (2018)

Narrowband ultraviolet B light treatment changes plasma concentrations of MMP-3, MMP-9 and TIMP-3 in psoriatic patients
por: Głażewska, Edyta Katarzyna, et al.
Publicado: (2017)

The Significance of Apolipoprotein E Measurement in the Screening of Fetal Down Syndrome
por: Buczyńska, Angelika, et al.
Publicado: (2020)

Influence of narrowband ultraviolet-B phototherapy on plasma concentration of matrix metalloproteinase-12 in psoriatic patients
por: Głażewska, Edyta K., et al.
Publicado: (2017)

Prenatal Screening of Trisomy 21: Could Oxidative Stress Markers Play a Role?
por: Buczyńska, Angelika, et al.
Publicado: (2021)

Novel Approaches to an Integrated Route for Trisomy 21 Evaluation
por: Buczyńska, Angelika, et al.
Publicado: (2021)

Brief Communication: Maternal Plasma Autoantibodies Screening in Fetal Down Syndrome
por: Charkiewicz, Karol, et al.
Publicado: (2016)

Utility of Matrix Metalloproteinases in the Diagnosis, Monitoring and Prognosis of Ovarian Cancer Patients
por: Kicman, Aleksandra, et al.
Publicado: (2022)

CXC ELR-Positive Chemokines as Diagnostic and Prognostic Markers for Breast Cancer Patients
por: Motyka, Joanna, et al.
Publicado: (2023)

ROC analysis of selected matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in psoriatic patients
por: Glazewska, Edyta K., et al.
Publicado: (2018)

Levels of Selected Matrix Metalloproteinases, Their Inhibitors in Saliva, and Oral Status in Juvenile Idiopathic Arthritis Patients vs. Healthy Controls
por: Kobus, Agnieszka, et al.
Publicado: (2019)

Plasma Concentrations of Matrilysins MMP-7 and MMP-26 as Diagnostic Biomarkers in Breast Cancer
por: Piskór, Barbara Maria, et al.
Publicado: (2021)

Maternal plasma angiogenic and inflammatory factor profiling in foetal Down syndrome
por: Zbucka-Kretowska, Monika, et al.
Publicado: (2017)

Plasma Level of MMP-10 May Be a Prognostic Marker in Early Stages of Breast Cancer
por: Piskór, Barbara Maria, et al.
Publicado: (2020)

Maternal Plasma and Amniotic Fluid Sphingolipids Profiling in Fetal Down Syndrome
por: Charkiewicz, Karol, et al.
Publicado: (2015)

Unstimulated salivary flow, pH, proteins and oral health in patients with Juvenile Idiopathic Arthritis
por: Kobus, Agnieszka, et al.
Publicado: (2017)

Serum Chemerin Concentration Is Associated with Proinflammatory Status in Chronic Coronary Syndrome
por: Szpakowicz, Anna, et al.
Publicado: (2021)

Maternal Plasma and Amniotic Fluid Chemokines Screening in Fetal Down Syndrome
por: Laudanski, Piotr, et al.
Publicado: (2014)

Plasma Chemokine CCL2 and Its Receptor CCR2 Concentrations as Diagnostic Biomarkers for Breast Cancer Patients
por: Lubowicka, Emilia, et al.
Publicado: (2018)

Plasma Levels of IL-17, VEGF, and Adrenomedullin and S-Cone Dysfunction of the Retina in Children and Adolescents without Signs of Retinopathy and with Varied Duration of Diabetes
por: Semeran, Kornel, et al.
Publicado: (2013)

Prenatal circulating microRNA signatures of foetal Down syndrome
por: Zbucka-Kretowska, Monika, et al.
Publicado: (2019)

Metformin Intervention—A Panacea for Cancer Treatment?
por: Buczyńska, Angelika, et al.
Publicado: (2022)

The Role of Oxidative Stress in Trisomy 21 Phenotype
por: Buczyńska, Angelika, et al.
Publicado: (2023)

Future Perspectives in Oxidative Stress in Trisomy 13 and 18 Evaluation
por: Buczyńska, Angelika, et al.
Publicado: (2022)

The Influence Of Intrauterine Pressure On Embryo Retention In A Catheter After Embryo Transfer
por: Kozikowska, Małgorzata, et al.
Publicado: (2019)

miRNAs as Predictive Factors in Early Diagnosis of Gestational Diabetes Mellitus
por: Juchnicka, Ilona, et al.
Publicado: (2022)

Matrilysins and Stromelysins in Pathogenesis and Diagnostics of Cancers
por: Piskór, Barbara Maria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_egdnjmjl3s72jqd64qv6dsv7bg